Key Considerations
in Oral Delivery of Peptides

Factors to Consider While Evaluating Oral Administration

By John Vrettos, PhD, Director, Formulation Development, & Kalpana Ramakrishnan, PhD, Manager, Business Development, Enteris BioPharma


    How did you hear about us?*

    EnterisBioPharma is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

    You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    By clicking submit below, you consent to allow EnterisBioPharma to store and process the personal information submitted above to provide you the content requested.

    Meet Enteris Biopharma at AAPS Pharmsci 360

    October 16-19, Boston


    To learn more about our technologies and CMO service offerings please fill out and submit the form.

      How did you hear about us?*

      I am interested in: